Dacuronium bromide

Dacuronium bromide
Clinical data
Other names	NB-68; 17β-Hydroxypancuronium bromide; 3α-(Acetyloxy)-17β-hydroxy-2β,16β-bis(1-methylpiperidinium-1-yl)-5α-androstane dibromide; 2β,16β-Dipiperidino-5α-androstane-3α,17β-diol 3α-acetate dimethobromide
Identifiers
	IUPAC name [(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-Hydroxy-10,13-dimethyl-2,16-bis(1-methylpiperidin-1-ium-1-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate;dibromide;
CAS Number	27115-86-2;
PubChem CID	14029396;
ChemSpider	16736917;
UNII	33482245B6;
ChEMBL	ChEMBL3138544;
ECHA InfoCard	100.043.834
Chemical and physical data
Formula	C33H58Br2N2O3
Molar mass	690.646 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@@H]([C@]2(C[C@@H]1[N+]4(CCCCC4)C)C)CC[C@]5([C@H]3C[C@@H]([C@@H]5O)[N+]6(CCCCC6)C)C.[Br-].[Br-];
	InChI InChI=1S/C33H58N2O3.2BrH/c1-23(36)38-30-20-24-12-13-25-26(33(24,3)22-29(30)35(5)18-10-7-11-19-35)14-15-32(2)27(25)21-28(31(32)37)34(4)16-8-6-9-17-34;;/h24-31,37H,6-22H2,1-5H3;2*1H/q+2;;/p-2/t24-,25+,26-,27-,28-,29-,30-,31-,32-,33-;;/m0../s1; Key:SUKULMJPMHYWKC-GMMLHHOXSA-L;

Dacuronium bromide (INN, BAN) (developmental code name NB-68) is an aminosteroid neuromuscular blocking agent which was never marketed.[1][2][3][4][5] It acts as a competitive antagonist of the nicotinic acetylcholine receptor (nAChR).[2]

References

J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 647–. ISBN 978-1-4757-2085-3.
I.K. Morton; Judith M. Hall (6 December 2012). Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Science & Business Media. pp. 90–. ISBN 978-94-011-4439-1.
Progress in Medicinal Chemistry. Elsevier. 1 January 1979. pp. 102–. ISBN 978-0-08-086264-4.
R.E.M. Bowden; B. Collier; R.D. Dripps; L.W. Duchen, G.E. Hale Enderby, B.L. Ginsborg, S. Head, F. Hobbiger, D.H. Jenkinson, F.C. MacIntosh, S.E. Smith (13 March 2013). Neuromuscular Junction. Springer Science & Business Media. pp. 421–. ISBN 978-3-642-45476-9.CS1 maint: multiple names: authors list (link)
Dimitry A. Kharkevich (6 December 2012). New Neuromuscular Blocking Agents: Basic and Applied Aspects. Springer Science & Business Media. pp. 201–202, 213. ISBN 978-3-642-70682-0.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.